NetApp, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NetApp, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Apr 27, 2012 | $1.70B | Jun 19, 2012 |
| FY2012 | Jan 27, 2012 | $1.57B | Jun 19, 2012 |
| FY2012 | Oct 28, 2011 | $1.51B | Jun 19, 2012 |
| FY2012 | Jul 29, 2011 | $1.46B | Jun 19, 2012 |
| FY2011 | Apr 29, 2011 | $1.43B | Jun 23, 2011 |
| FY2011 | Jan 28, 2011 | $1.29B | Jun 23, 2011 |
| FY2011 | Oct 29, 2010 | $1.25B | Jun 23, 2011 |
| FY2011 | Jul 30, 2010 | $1.15B | Jun 23, 2011 |
| FY2011 | Apr 30, 2010 | $1.17B | Jun 23, 2011 |
| FY2011 | Jan 29, 2010 | $1.01B | Jun 23, 2011 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $6.57B | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $6.27B | Jun 9, 2025 |
| FY2025 | Apr 28, 2023 | $6.36B | Jun 9, 2025 |
| FY2024 | Apr 29, 2022 | $6.32B | Jun 10, 2024 |
| FY2023 | Apr 30, 2021 | $5.74B | Jun 14, 2023 |
| FY2022 | Apr 24, 2020 | $5.41B | Jun 16, 2022 |
| FY2021 | Apr 26, 2019 | $6.15B | Jun 21, 2021 |
| FY2020 | Apr 27, 2018 | $5.92B | Jun 15, 2020 |
| FY2019 | Apr 28, 2017 | $5.49B | Jun 18, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Apr 27, 2018 | $5.91B | Jun 19, 2018 |
| FY2018 | Apr 28, 2017 | $5.52B | Jun 19, 2018 |
| FY2018 | Apr 29, 2016 | $5.55B | Jun 19, 2018 |
| FY2017 | Apr 24, 2015 | $6.12B | Jun 20, 2017 |
| FY2014 | Apr 25, 2014 | $1.65B | Jun 17, 2014 |
| FY2014 | Jan 24, 2014 | $1.61B | Jun 17, 2014 |
| FY2014 | Oct 25, 2013 | $1.55B | Jun 17, 2014 |
| FY2014 | Jul 26, 2013 | $1.52B | Jun 17, 2014 |
| FY2014 | Apr 26, 2013 | $1.72B | Jun 17, 2014 |
| FY2014 | Jan 25, 2013 | $1.63B | Jun 17, 2014 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $4.61B | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $4.43B | Jun 9, 2025 |
| FY2025 | Apr 28, 2023 | $4.21B | Jun 9, 2025 |
| FY2024 | Apr 29, 2022 | $4.22B | Jun 10, 2024 |
| FY2023 | Apr 30, 2021 | $3.82B | Jun 14, 2023 |
| FY2022 | Apr 24, 2020 | $3.62B | Jun 16, 2022 |
| FY2021 | Apr 26, 2019 | $3.95B | Jun 21, 2021 |
| FY2020 | Apr 27, 2018 | $3.71B | Jun 15, 2020 |
| FY2019 | Apr 28, 2017 | $3.36B | Jun 18, 2019 |
| FY2018 | Apr 29, 2016 | $3.37B | Jun 19, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $1.19B | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $986.00M | Jun 9, 2025 |
| FY2025 | Apr 28, 2023 | $1.27B | Jun 9, 2025 |
| FY2024 | Apr 29, 2022 | $937.00M | Jun 10, 2024 |
| FY2023 | Apr 30, 2021 | $730.00M | Jun 14, 2023 |
| FY2022 | Apr 24, 2020 | $819.00M | Jun 16, 2022 |
| FY2021 | Apr 26, 2019 | $1.17B | Jun 21, 2021 |
| FY2020 | Apr 27, 2018 | $116.00M | Jun 15, 2020 |
| FY2019 | Apr 28, 2017 | $481.00M | Jun 18, 2019 |
| FY2018 | Apr 29, 2016 | $229.00M | Jun 19, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $1.34B | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $1.21B | Jun 9, 2025 |
| FY2025 | Apr 28, 2023 | $1.02B | Jun 9, 2025 |
| FY2024 | Apr 29, 2022 | $1.16B | Jun 10, 2024 |
| FY2023 | Apr 30, 2021 | $1.03B | Jun 14, 2023 |
| FY2022 | Apr 24, 2020 | $945.00M | Jun 16, 2022 |
| FY2021 | Apr 26, 2019 | $1.22B | Jun 21, 2021 |
| FY2020 | Apr 27, 2018 | $1.16B | Jun 15, 2020 |
| FY2019 | Apr 28, 2017 | $621.00M | Jun 18, 2019 |
| FY2018 | Apr 29, 2016 | $348.00M | Jun 19, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $1.01B | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $1.03B | Jun 9, 2025 |
| FY2025 | Apr 28, 2023 | $956.00M | Jun 9, 2025 |
| FY2024 | Apr 29, 2022 | $881.00M | Jun 10, 2024 |
| FY2023 | Apr 30, 2021 | $881.00M | Jun 14, 2023 |
| FY2022 | Apr 24, 2020 | $847.00M | Jun 16, 2022 |
| FY2021 | Apr 26, 2019 | $827.00M | Jun 21, 2021 |
| FY2020 | Apr 27, 2018 | $783.00M | Jun 15, 2020 |
| FY2019 | Apr 28, 2017 | $779.00M | Jun 18, 2019 |
| FY2018 | Apr 29, 2016 | $861.00M | Jun 19, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $1.51B | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $1.69B | Jun 9, 2025 |
| FY2025 | Apr 28, 2023 | $1.11B | Jun 9, 2025 |
| FY2024 | Apr 29, 2022 | $1.21B | Jun 10, 2024 |
| FY2023 | Apr 30, 2021 | $1.33B | Jun 14, 2023 |
| FY2022 | Apr 24, 2020 | $1.06B | Jun 16, 2022 |
| FY2021 | Apr 26, 2019 | $1.34B | Jun 21, 2021 |
| FY2020 | Apr 27, 2018 | $1.48B | Jun 15, 2020 |
| FY2019 | Apr 28, 2017 | $986.00M | Jun 18, 2019 |
| FY2018 | Apr 29, 2016 | $974.00M | Jun 19, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $168.00M | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $155.00M | Jun 9, 2025 |
| FY2025 | Apr 28, 2023 | $239.00M | Jun 9, 2025 |
| FY2024 | Apr 29, 2022 | $226.00M | Jun 10, 2024 |
| FY2023 | Apr 30, 2021 | $162.00M | Jun 14, 2023 |
| FY2022 | Apr 24, 2020 | $124.00M | Jun 16, 2022 |
| FY2021 | Apr 26, 2019 | $173.00M | Jun 21, 2021 |
| FY2020 | Apr 27, 2018 | $145.00M | Jun 15, 2020 |
| FY2019 | Apr 28, 2017 | $175.00M | Jun 18, 2019 |
| FY2018 | Apr 29, 2016 | $160.00M | Jun 19, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $10.82B | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $9.89B | Jun 9, 2025 |
| FY2024 | Apr 28, 2023 | $9.82B | Jun 10, 2024 |
| FY2023 | Apr 29, 2022 | $10.03B | Jun 14, 2023 |
| FY2022 | Apr 30, 2021 | $9.36B | Jun 16, 2022 |
| FY2021 | Apr 24, 2020 | $7.52B | Jun 21, 2021 |
| FY2020 | Apr 26, 2019 | $8.74B | Jun 15, 2020 |
| FY2019 | Apr 27, 2018 | $9.99B | Jun 18, 2019 |
| FY2018 | Apr 28, 2017 | $9.49B | Jun 19, 2018 |
| FY2017 | Apr 29, 2016 | $10.04B | Jun 20, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $9.78B | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $8.74B | Jun 9, 2025 |
| FY2024 | Apr 28, 2023 | $8.66B | Jun 10, 2024 |
| FY2023 | Apr 29, 2022 | $9.19B | Jun 14, 2023 |
| FY2022 | Apr 30, 2021 | $8.68B | Jun 16, 2022 |
| FY2021 | Apr 24, 2020 | $7.28B | Jun 21, 2021 |
| FY2020 | Apr 26, 2019 | $7.65B | Jun 15, 2020 |
| FY2019 | Apr 27, 2018 | $7.72B | Jun 18, 2019 |
| FY2018 | Apr 28, 2017 | $6.71B | Jun 19, 2018 |
| FY2017 | Apr 29, 2016 | $7.16B | Jun 20, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $1.04B | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $1.15B | Jun 9, 2025 |
| FY2025 | Apr 28, 2023 | $1.16B | Jun 9, 2025 |
| FY2025 | Apr 29, 2022 | $838.00M | Jun 9, 2025 |
| FY2024 | Apr 30, 2021 | $685.00M | Jun 10, 2024 |
| FY2023 | Apr 24, 2020 | $242.00M | Jun 14, 2023 |
| FY2022 | Apr 26, 2019 | $1.09B | Jun 16, 2022 |
| FY2021 | Apr 27, 2018 | $2.28B | Jun 21, 2021 |
| FY2020 | Apr 28, 2017 | $2.95B | Jun 15, 2020 |
| FY2019 | Apr 29, 2016 | $2.88B | Jun 18, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $2.72B | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $2.76B | Jun 9, 2025 |
| FY2025 | Apr 28, 2023 | $2.76B | Jun 9, 2025 |
| FY2024 | Apr 29, 2022 | $2.35B | Jun 10, 2024 |
| FY2023 | Apr 30, 2021 | $2.04B | Jun 14, 2023 |
| FY2022 | Apr 24, 2020 | $1.78B | Jun 16, 2022 |
| FY2021 | Apr 26, 2019 | $1.74B | Jun 21, 2021 |
| FY2020 | Apr 27, 2018 | $1.74B | Jun 15, 2020 |
| FY2019 | Apr 28, 2017 | $1.68B | Jun 18, 2019 |
| FY2018 | Apr 29, 2016 | $1.68B | Jun 19, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $0 | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $208.00M | Jun 9, 2025 |
| FY2024 | Apr 28, 2023 | $265.00M | Jun 10, 2024 |
| FY2023 | Apr 29, 2022 | $122.00M | Jun 14, 2023 |
| FY2022 | Apr 30, 2021 | $211.00M | Jun 16, 2022 |
| FY2021 | Apr 24, 2020 | $0 | Jun 21, 2021 |
| FY2020 | Apr 26, 2019 | $0 | Jun 15, 2020 |
| FY2019 | Apr 27, 2018 | ($9.00M) | Jun 18, 2019 |
| FY2018 | Apr 28, 2017 | $40.00M | Jun 19, 2018 |
| FY2017 | Apr 29, 2016 | $0 | Jun 20, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $2.74B | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $1.90B | Jun 9, 2025 |
| FY2024 | Apr 28, 2023 | $2.32B | Jun 10, 2024 |
| FY2023 | Apr 29, 2022 | $4.11B | Jun 14, 2023 |
| FY2022 | Apr 30, 2021 | $4.53B | Jun 16, 2022 |
| FY2021 | Apr 24, 2020 | $2.66B | Jun 21, 2021 |
| FY2020 | Apr 26, 2019 | $2.33B | Jun 15, 2020 |
| FY2019 | Apr 27, 2018 | $2.94B | Jun 18, 2019 |
| FY2018 | Apr 28, 2017 | $2.44B | Jun 19, 2018 |
| FY2018 | Apr 29, 2016 | $2.87B | Jun 19, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | $3.24B | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | $2.39B | Jun 9, 2025 |
| FY2024 | Apr 28, 2023 | $2.39B | Jun 10, 2024 |
| FY2023 | Apr 29, 2022 | $2.64B | Jun 14, 2023 |
| FY2022 | Apr 30, 2021 | $2.63B | Jun 16, 2022 |
| FY2021 | Apr 24, 2020 | $1.15B | Jun 21, 2021 |
| FY2020 | Apr 26, 2019 | $1.54B | Jun 15, 2020 |
| FY2019 | Apr 27, 2018 | $1.54B | Jun 18, 2019 |
| FY2018 | Apr 28, 2017 | $1.49B | Jun 19, 2018 |
| FY2017 | Apr 29, 2016 | $1.49B | Jun 20, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | 5 | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | 4 | Jun 9, 2025 |
| FY2025 | Apr 28, 2023 | 5 | Jun 9, 2025 |
| FY2024 | Apr 29, 2022 | 4 | Jun 10, 2024 |
| FY2023 | Apr 30, 2021 | 3 | Jun 14, 2023 |
| FY2022 | Apr 24, 2020 | 3 | Jun 16, 2022 |
| FY2021 | Apr 26, 2019 | 4 | Jun 21, 2021 |
| FY2020 | Apr 27, 2018 | 0 | Jun 15, 2020 |
| FY2019 | Apr 28, 2017 | 1 | Jun 18, 2019 |
| FY2018 | Apr 29, 2016 | 0 | Jun 19, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | 5 | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | 4 | Jun 9, 2025 |
| FY2025 | Apr 28, 2023 | 5 | Jun 9, 2025 |
| FY2024 | Apr 29, 2022 | 4 | Jun 10, 2024 |
| FY2023 | Apr 30, 2021 | 3 | Jun 14, 2023 |
| FY2022 | Apr 24, 2020 | 3 | Jun 16, 2022 |
| FY2021 | Apr 26, 2019 | 4 | Jun 21, 2021 |
| FY2020 | Apr 27, 2018 | 0 | Jun 15, 2020 |
| FY2019 | Apr 28, 2017 | 1 | Jun 18, 2019 |
| FY2018 | Apr 29, 2016 | 0 | Jun 19, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 25, 2025 | 201.00M | Jun 9, 2025 |
| FY2025 | Apr 26, 2024 | 206.00M | Jun 9, 2025 |
| FY2024 | Apr 28, 2023 | 212.00M | Jun 10, 2024 |
| FY2023 | Apr 29, 2022 | 220.00M | Jun 14, 2023 |
| FY2022 | Apr 30, 2021 | 222.00M | Jun 16, 2022 |
| FY2021 | Apr 24, 2020 | 219.00M | Jun 21, 2021 |
| FY2020 | Apr 26, 2019 | 240.00M | Jun 15, 2020 |
| FY2019 | Apr 27, 2018 | 263.00M | Jun 18, 2019 |
| FY2018 | Apr 28, 2017 | 269.00M | Jun 19, 2018 |
| FY2017 | Apr 29, 2016 | 281.00M | Jun 20, 2017 |